This is simply not the case except when talking about a totally untested vaccine. The whole point of phase III trials is to confirm "safety and efficacy" in a wide population. Moderna, for instance, aims to enroll 30k people in it's (currently ongoing) phase III trial. After that, it's just a matter of data analysis. The FDA would certainly not approve a vaccine that had comorbidity higher than the disease it is trying to treat.